LIMS Biobanking Accelerator Supports Covid-19 Testing and Research
The new solution is designed to enable laboratories to enter biospecimens into a biobank and rapidly begin conducting covid-19-related testing and research.
Read MorePosted by Laurie Bonner | May 8, 2020 | Covid 19 |
The new solution is designed to enable laboratories to enter biospecimens into a biobank and rapidly begin conducting covid-19-related testing and research.
Read MorePosted by Laurie Bonner | May 7, 2020 | Covid 19 |
Microproof SARS-CoV-2 screening/identification kits run on many commonly used real-time PCR instruments. The test returns results in less than 1.5 hours.
Read MorePosted by Laurie Bonner | May 7, 2020 | Covid 19 |
Genalyte currently has the capacity to test 250,000 patients per month; the company is scaling up to test more than 7,500,000 patients per month by September.
Read MorePosted by Laurie Bonner | May 7, 2020 | Covid 19 |
In the United States, the digital pathology software will support the need for remote pathology brought about by the covid-19 pandemic.
Read MorePosted by | May 6, 2020 | Covid 19, Emerging & Zoonotic Diseases, Infectious Diseases |
The goal is to inform the medical community about the existence of immunity to covid-19 in healthcare settings and eventually the population at large.
Read More